These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3908619)

  • 41. Randomized trial with Poly A-Poly U as adjuvant therapy complementing surgery in patients with breast cancer: in vitro study of cellular immunity.
    Lacour F; Delage G; Spira A; Nahon-Merlin E; Lacour J; Michelson AM; Bayet S
    Recent Results Cancer Res; 1978; 68():129-38. PubMed ID: 379931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U).
    Singh SK; Marquet RL; Westbroek DL; Jeekel J
    Cancer Immunol Immunother; 1987; 25(3):242-4. PubMed ID: 3677125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhancement of interferon-mediated protein kinase in mouse and human plasma in response to treatment with polyadenylic-polyuridylic acid (poly A:poly U).
    Hovanessian AG; Rivière Y; Montagnier L; Michelson M; Lacour J; Lacour F
    J Interferon Res; 1982; 2(2):209-15. PubMed ID: 6181177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthetic polyribonucleotides: current role and potential use in oncological practice.
    Khan AL; Heys SD; Eremin O
    Eur J Surg Oncol; 1995 Apr; 21(2):224-7. PubMed ID: 7720906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prophylactic therapy of spontaneous leukemia in AKR mice by polyadenylic-polyuridylic acid.
    Drake WP; Cimino EF; Mardiney MR; Sutherland JC
    J Natl Cancer Inst; 1974 Mar; 52(3):941-4. PubMed ID: 4596992
    [No Abstract]   [Full Text] [Related]  

  • 46. [Adjuvant therapy in operable breast neoplasms].
    Høst H
    Tidsskr Nor Laegeforen; 1979 Feb; 99(6):309-11. PubMed ID: 425097
    [No Abstract]   [Full Text] [Related]  

  • 47. The measurement of plant polyadenylic acid by hybridisation with radioactive polyuridylic acid.
    Covey SN; Grierson D
    Planta; 1976 Jan; 131(1):75-9. PubMed ID: 24424698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tumor therapy using polynucleotide dye complexes].
    Ganzinger U; Unger FM; Moser K; Rainer H; Deutsch E
    Verh Dtsch Ges Inn Med; 1975; 81():1621-4. PubMed ID: 1227036
    [No Abstract]   [Full Text] [Related]  

  • 49. Mouse thymocyte membrane uptake of polyadenylic-polyuridylic acid complexes.
    Mutchnick MG; Han IH; Johnson AG
    Proc Soc Exp Biol Med; 1977 Feb; 154(2):264-8. PubMed ID: 840864
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunochemical characterization of polyribonucleotides.
    Panijel J; Souleil C; Cayeux P
    Science; 1966 May; 152(3723):773-5. PubMed ID: 17797450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spectrophotometric, light scattering, and titration studies upon the interaction of polyadenylic and polyuridylic acids.
    BEERS RF; STEINER RF
    Nature; 1958 Jan; 181(4601):30-2. PubMed ID: 13493587
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumour actions of interferons: implications for cancer therapy.
    Parker BS; Rautela J; Hertzog PJ
    Nat Rev Cancer; 2016 Mar; 16(3):131-44. PubMed ID: 26911188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice.
    Bloksma N; Hofhuis FM
    Cancer Immunol Immunother; 1987; 24(2):165-71. PubMed ID: 3829051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
    Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
    Eur J Surg Oncol; 1988 Aug; 14(4):311-6. PubMed ID: 3044833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
    [No Abstract]   [Full Text] [Related]  

  • 56. Adjuvant treatment with polyadenylic-polyuridylic acid in operable breast cancer: updated results of a randomised trial.
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):589-92. PubMed ID: 6421391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].
    Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
    Chirurgie; 1988; 114(6):516-23. PubMed ID: 3067998
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
    Lacour J
    J Biol Response Mod; 1985 Oct; 4(5):538-43. PubMed ID: 3908619
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.